3600.HK
Strong BuyFull HouseAI neutralModern Dental Group Limited · Healthcare · Hong Kong · $970M
HKD 7.80 +0.6% · close 5 Oct · scored 3 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Read our full research report on 3600.HK (Apr 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Modern Dental is a market leader in a highly fragmented, essential-care sector with high barriers to entry and consistent demand. While it fits the Terry Smith quality compounder mold, the lack of a clear macro tailwind relative to the current geopolitical environment makes it a solid, if less asymmetric, hold. Recent small-scale buybacks demonstrate management's belief in intrinsic value.
ABOUT MODERN DENTAL GROUP LIMITED
Read
Modern Dental Group Limited is a leading global provider of custom-made dental prosthetics and orthodontic appliances, offering a comprehensive range of products including crowns, bridges, and dentures. The company boasts a significant competitive advantage through its vertically integrated operations, extensive global distribution network, and advanced CAD/CAM digital dentistry capabilities. As one of the largest players worldwide, Modern Dental benefits from economies of scale and strong relationships with dental practitioners globally.
FINANCIAL SUMMARY (HKD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 2.8B | 3.2B | 3.4B | 3.7B | 9.7% | 3.9B |
| EPS (HKD) | 0.38 | 0.23 | 0.42 | 0.43 | 0.64 | 14.0% | 0.73 |
| Shares | — | 955.0M | 948.4M | 942.2M | 934.9M | -2.1% | 934.2M |
| Debt | — | 788.2M | 852.2M | 924.2M | 654.1M | -6.0% | 609.4M |
| Equity | — | 2.3B | 2.6B | 2.7B | 3.3B | 12.3% | — |
| Op CF | — | 258.3M | 575.8M | 521.2M | 763.1M | 43.5% | 803.6M |
| Inv CF | — | -227.9M | -155.0M | -145.5M | -278.1M | — | — |
| Fin CF | — | -201.8M | -173.6M | -227.7M | -575.7M | — | — |
Calmer than 55% of stocks we rank over the past year (39% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3600.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3600.HK | Modern Dental Group Limited(you) | $970M | 99 | Strong Buy |
| 1612.HK | Vincent Medical Holdings Limited | $56M | 93 | Strong Buy |
| 2005.HK | SSY Group Limited | $1.0B | 88 | Strong Buy |
| 3613.HK | Beijing Tong Ren Tang Chinese Medicine Company Limited | $582M | 93 | Strong Buy |
| 6929.HK | OrbusNeich Medical Group Holdings Limited | $387M | 95 | Strong Buy |
| 3320.HK | China Resources Pharmaceutical Group Limited | $3.4B | 95 | Strong Buy |
| 1830.HK | Perfect Medical Health Management Limited | $201M | 100 | Strong Buy |
| 3839.HK | CPBIO Holding Company Limited | $249M | 94 | Strong Buy |
| 2348.HK | Dawnrays Pharmaceutical (Holdings) Limited | $188M | 99 | Strong Buy |
| 2633.HK | Jacobson Pharma Corporation Limited | $242M | 92 | Strong Buy |
Peer medians: ROE 5.7% · P/E 10.0x · Gross margin 42.9%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.